Metabolomic Diagnostics secures €1.6M investment

DC 16/06/2016 - REPRO FREE FREE PIC Irish biotech company, Metabolomic Diagnostics, has secured a further €2 million in venture funding to help complete PrePsia, its pre-eclampsia screening test for first time pregnant mothers.  Pictured here with 4 day old baby Molly, are Frank Walsh, Partner, Enterprise Equity, Bill Liao, European Investment Partner, SOSventures, Charles Garvey, CEO, Metabolomic Diagnostics, and Prof. Louise Kenny, Consultant Obstetrician at CUMH & Director of the INFANT Centre. Pic: Diane Cusack

Frank Walsh, Partner, Enterprise Equity, Bill Liao, European Investment Partner, SOSventures, Charles Garvey, CEO, Metabolomic Diagnostics, and Prof. Louise Kenny, Consultant Obstetrician at CUMH & Director of the INFANT Centre.

Irish biotech company, Metabolomic Diagnostics, has secured an additional €1.6 million from investors to help complete PrePsia™, its new screening test for pre-eclampsia in first time pregnant mothers.

Continue Reading

No more posts.